Attenuated serum vasoactive intestinal peptide concentrations are correlated with disease severity of non-traumatic osteonecrosis of femoral head

被引：10
|
作者：
Liu, Ming [1 ,2 ]
Zhao, Gan [1 ,3 ]
Wei, Biao-Fang [4 ]
机构：
[1] Guangzhou Univ Chinese Med, Guangzhou, Guangdong, Peoples R China
[2] Linyi Peoples Hosp, Dept Pain, Linyi, Shandong, Peoples R China
[3] Linyi Tradit Chinese Med Hosp, Dept Sports Med, Linyi, Shandong, Peoples R China
[4] Linyi Peoples Hosp, Dept Orthoped, Jie Fang Rd East 27, Linyi 276003, Shandong, Peoples R China
来源：
JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH | 2021年 / 16卷 / 01期
关键词：
Non-traumatic osteonecrosis of the femoral head; Disease severity; Vasoactive intestinal peptide; VIP; EXPRESSION;
D O I：
10.1186/s13018-021-02486-3
中图分类号：
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];
学科分类号：
摘要：
Background and objectiveThe neuropeptide vasoactive intestinal peptide is a 28-amino acid neuropeptide that has been shown to stimulate bone repair and angiogenesis. The purpose of this study was to explore the potential role of serum VIP concentration in osteonecrosis of femoral trauma (ONFH).MethodsOne hundred five patients diagnosed with non-traumatic ONFH and 103 healthy individuals were enrolled in our study. Serum VIP, tumor necrosis factor-alpha (TNF-alpha), interluekin-1 beta (IL-1 beta), and macrophage colony-stimulating factor (M-CSF) levels also were detected using the commercial ELISA kit. Radiographic progression was evaluated using FICAT classification. The clinical severity of ONFH was assessed by visual analog score (VAS) and Harris Hip Score (HHS). Receiver-operating characteristic (ROC) curve was performed to test the potential diagnostic value of VIP in radiographic progression.ResultsThe serum VIP level of patients with non-traumatic ONFH was significantly lower than that of healthy controls. There was no significant difference between the alcohol group, the steroid-induction group, and the idiopathic group. Serum VIP levels were significantly higher in ONFH patients with femoral head pre-collapse stage than collapse stage. Serum VIP levels were significantly lower. FICAT 4 non-traumatic ONFH patients had significantly lower serum concentrations of VIP when compared with FICAT 3 and FICAT 2. Moreover, serum VIP levels were significantly lower in ONFH patients with FICAT 3 than FICAT 2. Serum VIP levels were negatively related to FICAT stage. In addition, serum VIP levels were negatively associated with VAS score and positively associated with HHS score. Last, we found serum VIP levels were negatively associated with serum TNF-alpha and IL-1 beta levels. ROC curve analysis indicated that decreased serum VIP could serve as a decent biomarker with regard to the diagnosis of radiographic progression.ConclusionAttenuated serum VIP concentrations are correlated with disease severity of non-traumatic ONFH. Decreased serum VIP may serve as a potential indicator of non-traumatic ONFH.
引用
收藏
页数：7
相关论文
共 50 条
  • [41] Core decompression combined with implantation of a demineralised bone matrix for non-traumatic osteonecrosis of the femoral head
    L. Helbig
    H. G. Simank
    M. Kroeber
    G. Schmidmaier
    P. A. Grützner
    T. Guehring
    Archives of Orthopaedic and Trauma Surgery, 2012, 132 : 1095 - 1103
  • [42] Plasma ghrelin and von Willebrand Factor levels in patients with non-traumatic osteonecrosis of the femoral head
    Li, Chenggang
    Shen, Lin
    Yang, Yanping
    Shuai, Bo
    Xu, Xiaojuan
    Ma, Chen
    HIP INTERNATIONAL, 2015, 25 (01) : 76 - 81
  • [43] LncRNA AWPPH participates in the development of non-traumatic osteonecrosis of femoral head by upregulating Runx2
    Chen, Xiantao
    Li, Jing
    Liang, Dawei
    Zhang, Leilei
    Wang, Qingfeng
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 19 (01) : 153 - 159
  • [44] Endothelial nitric oxide synthase gene intron 4 polymorphism in non-traumatic osteonecrosis of the femoral head
    Jacek Gagala
    Monika Buraczynska
    Tomasz Mazurkiewicz
    Andrzej Ksiazek
    International Orthopaedics, 2013, 37 : 1381 - 1385
  • [45] A higher frequency of peripheral blood activated B cells in patients with non-traumatic osteonecrosis of the femoral head
    Zhang, Haiyu
    Xiao, Fei
    Liu, Yijun
    Zhao, Ding
    Shan, Yuxing
    Jiang, Yanfang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2014, 20 (01) : 95 - 100
  • [46] THE DIAGNOSTIC-VALUE OF MAGNETIC-RESONANCE IMAGING IN NON-TRAUMATIC OSTEONECROSIS OF THE FEMORAL-HEAD
    HAUZEUR, JP
    PASTEELS, JL
    SCHOUTENS, A
    HINSENKAMP, M
    APPELBOOM, T
    CHOCHRAD, I
    PERLMUTTER, N
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1989, 71A (05): : 641 - 649
  • [47] Long-term outcomes of Phemister bone grafting for patients with non-traumatic osteonecrosis of the femoral head
    Cheng-Ta Wu
    Shih-Hsiang Yen
    Po-Chun Lin
    Jun-Wen Wang
    International Orthopaedics, 2019, 43 : 579 - 587
  • [48] Long-term outcomes of Phemister bone grafting for patients with non-traumatic osteonecrosis of the femoral head
    Wu, Cheng-Ta
    Yen, Shih-Hsiang
    Lin, Po-Chun
    Wang, Jun-Wen
    INTERNATIONAL ORTHOPAEDICS, 2019, 43 (03) : 579 - 587
  • [49] Endothelial nitric oxide synthase gene intron 4 polymorphism in non-traumatic osteonecrosis of the femoral head
    Gagala, Jacek
    Buraczynska, Monika
    Mazurkiewicz, Tomasz
    Ksiazek, Andrzej
    INTERNATIONAL ORTHOPAEDICS, 2013, 37 (07) : 1381 - 1385
  • [50] A prospective cohort study of the clinical presentation of non-traumatic osteonecrosis of the femoral head: spine and knee symptoms as clinical presentation of hip osteonecrosis
    Hauzeur, Jean-Philippe
    Malaise, Michel
    de Maertelaer, Viviane
    INTERNATIONAL ORTHOPAEDICS, 2016, 40 (07) : 1347 - 1351
12345